drug
as of 2026-07-01Naltrexone
naltrexone
MeSH D009271
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Yale University
4 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
4
Naltrexone for Antipsychotic-Induced Weight Gain
NCT01866098—Completed
Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia
NCT03132571Phase 2Terminated
Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia
NCT02736474Phase 4Completed
Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects
NCT00567034Phase 1Completed
KOLs & investigators
3
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
KOL